Cost-Effectiveness of Follitropin Delta Compared with Follitropins Alfa and Beta in Controlled Ovarian Stimulation for Assisted Reproductive Technologies (ART) in France

20260 citationsJournal Articlegold Open Access

Authors

S. Hamamah · Hôpital Arnaud de Villeneuve

Jeremy Carette · Expertise Engenharia (Brazil)

Marie Markert · Ferring Pharmaceuticals (Denmark)

Abstract

Follitropin delta provides an effective alternative to follitropin alfa and beta with a potential cost-savings opportunity, excluding the delivery cost, due to higher OP and LB rates in the fresh cycle transfers.

Topics & Keywords

Ovarian function and disorders Reproductive Biology and Fertility Reproductive Health and Technologies

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: PharmacoEconomics - Open

DOI: 10.1007/s41669-026-00641-2

Field-Weighted Citation Impact: 0.00